[{"Assets_0_FY_USD":55306366.0,"CommonStockSharesOutstanding_0_FY_shares":53208489.0,"EarningsPerShareBasic_1_FY_USD":-0.12,"EarningsPerShareBasic_4_FY_USD":-0.25,"EarningsPerShareDiluted_1_FY_USD":-0.12,"EarningsPerShareDiluted_4_FY_USD":-0.25,"NetIncomeLoss_1_FY_USD":-2679335.0,"NetIncomeLoss_4_FY_USD":-6612047.0,"StockholdersEquity_0_FY_USD":48453205.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":34640308.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":34640308.0,"Assets_0_Q1_USD":51048185.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":296662.0,"NetIncomeLoss_1_Q1_USD":-4257152.0,"StockholdersEquity_0_Q1_USD":44750588.0,"Ticker":"VERU","CIK":"863894","name":"VERU INC.","OfficialName":"Veru Inc. Common Stock","form":"10-K","period":"20170930","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1011836411.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180214"}]